Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203926 · ClinicalTrials.gov registry record · NA
Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study
A NA study of Sacroiliitis, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT05203926 is a NA study of Sacroiliitis that has completed, run by NYU Langone Health. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05203926, a NA study of Sacroiliitis, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to further define and characterize imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE and assess the natural history and outcome of these cases by using standard magnetic resonance imaging (MRI) and x-ray of the sacroiliac joints.
Conditions Studied
Interventions
- PROCEDURE MRI scan
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2023-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05203926
The ClinicalTrials.gov registry entry for NCT05203926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sacroiliitis appearing as the primary indexed condition, and to 1 intervention - of which MRI scan is the first listed.
NCT05203926 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05203926 about?
NCT05203926 is a clinical study titled "Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study". This study aims to further define and characterize imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE and assess the natural history and outcome of these cases by using standard magnetic resonance imaging...
What is the current status of trial NCT05203926?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2022-03-14. Estimated completion is 2023-11-04.
What conditions does trial NCT05203926 study?
This clinical trial studies the following conditions: Sacroiliitis.
What interventions are being tested in trial NCT05203926?
The interventions under investigation include: MRI scan (PROCEDURE).
Who is sponsoring clinical trial NCT05203926?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05203926 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.